Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
Business Wire (May 8, 2013)
-
-
Business Wire (Apr 25, 2013)
-
Business Wire (Apr 25, 2013)
-
-
Business Wire (Apr 11, 2013)
-
-
-
-
Business Wire (Mar 14, 2013)
-
-
-
Business Wire (Mar 5, 2013)
-
-
Business Wire (Feb 28, 2013)
-
Business Wire (Feb 28, 2013)
-
Business Wire (Feb 25, 2013)
To learn more about Seeking Alpha Pro, click here.
-
-
-
-
-
Alexion To Power Higher Even Without Takeover BidSupreme Alpha • Thu, Aug 23, 2012 -
Alexion Pharmaceuticals: A Tricky Mix Of Biotech And PharmaStephen Simpson • Tue, Feb 14, 2012
-
-
-
-
Alexion Pharmaceuticals Bucking The Market's Downward TrendTed Stamas • Tue, Sep 13, 2011 -
Alexion Pharmaceuticals: Expanding Markets Point to Bigger ProfitsTodd Campbell • Wed, Apr 27, 2011
-
Alexion Pharmaceuticals: From Acquisition Target to AcquirerJason Chew • Mon, Feb 14, 2011 -
Alexion Pharma Has Plenty of Room to GrowJason Chew • Sun, Oct 24, 2010
-
-
Alexion Posts a Strong Quarter on Renewed SalesZacks Investment Research • Fri, Apr 23, 2010 -
Alexion: Hoping to Be Big in JapanZacks Investment Research • Mon, Apr 19, 2010
-
Alexion Pharma: Bounce Play?Notable Calls • Thu, Feb 21, 2008 -
Alexion Pharmaceuticals: Costs of Healthcare Rise to the ExtremeChad Brand • Fri, Mar 30, 2007 -
-
Alexion's CEO Discusses Q1 2012 Results - Earnings Call TranscriptTue, Apr 24, 2012
-
Alexion Pharmaceuticals Q4 2008 Earnings Call TranscriptThu, Feb 12, 2009
-
Alexion Pharmaceuticals Inc. Q3 2008 Earnings Conference Call TranscriptFri, Oct 24, 2008
-
Alexion Pharmaceuticals, Inc. Q2 2008 Earnings CallTue, Jul 29, 2008 • 1 Comment
-
Alexion Pharmaceuticals, Inc. Q1 2008 Earnings Call TranscriptWed, Apr 30, 2008
-
Alexion Pharmaceuticals, Inc. Q4 2007 Earnings Call TranscriptThu, Feb 14, 2008
-
at MarketWatch.com (Tue, 12:07PM)
-
at MarketWatch.com (May 10, 2013)
-
Business Wire (May 8, 2013)
-
at MarketWatch.com (Apr 25, 2013)
-
Business Wire (Apr 25, 2013)
-
Business Wire (Apr 25, 2013)
-
at MarketWatch.com (Apr 22, 2013)
-
Business Wire (Apr 11, 2013)
-
at CNBC.com (Apr 1, 2013)
-
at MarketWatch.com (Mar 28, 2013)
-
at CNBC.com (Mar 15, 2013)
-
Business Wire (Mar 14, 2013)
-
Business Wire (Mar 5, 2013)
-
Business Wire (Feb 28, 2013)
-
Business Wire (Feb 28, 2013)
-
Business Wire (Feb 25, 2013)
-
at CNBC.com (Feb 20, 2013)
-
Business Wire (Feb 14, 2013)
-
Business Wire (Feb 7, 2013)
-
Business Wire (Jan 31, 2013)
ALXN vs. ETF Alternatives
Company Description
Alexion Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of life-transforming therapeutic products. The company offers Soliris (eculizumab), a therapeutic product for the treatment of patients with paroxysmal nocturnal hemoglobinuria (PNH), a... More
